SCHEMBL1008658

SCHEMBL1008658

NC(=O)CCN1CCCC(N)C1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.58
BCHE P06276 3/20 0.42
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
POLB P06746 2/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
HRH2 P25021 1/20 0.36
HRH1 P35367 1/20 0.36
KMT2A Q03164 1/20 0.35
PTPN11 Q06124 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 2/20 0.35
PLK1 P53350 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1008216 1.00 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL1010139 1.00 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL12635273 0.84 BCHE (0.41) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL12635280 0.84 BCHE (0.41) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL1008402 0.82 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL1007513 0.82 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL1007512 0.82 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL1007934 0.82 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL1006793 0.82 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB
SCHEMBL1007857 0.82 L3MBTL1 (0.58) L3MBTL1BCHEMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105488-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN CHLORION PHARMA, INC. (CA) 2011-05-05 US claimed
EP-2268616-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN Chlorion Pharma, Inc. (CA) 2011-01-05 EP claimed
WO-2009114950-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN CHLORION PHARMA, INC. (CA) 2009-09-24 WO claimed
US-20110105488-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN CHLORION PHARMA, INC. (CA) 2011-05-05 US disclosed
EP-2268616-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN Chlorion Pharma, Inc. (CA) 2011-01-05 EP disclosed
WO-2009114950-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN CHLORION PHARMA, INC. (CA) 2009-09-24 WO disclosed
WO-2009114950-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN CHLORION PHARMA, INC. (CA) 2009-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105488-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN PAM, PNN, NOD1 L3MBTL1 3671/4885BCHE 1420/4885MAPT 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.